BML, Inc. (TYO:4694)
3,675.00
+20.00 (0.55%)
Aug 26, 2026, 3:30 PM JST
BML, Inc. Revenue
BML, Inc. had revenue of 39.04B JPY in the quarter ending June 30, 2026, with 2.66% growth. This brings the company's revenue in the last twelve months to 151.27B, up 3.88% year-over-year. In the fiscal year ending March 31, 2026, BML, Inc. had annual revenue of 150.26B with 4.94% growth.
Revenue (ttm)
151.27B
Revenue Growth
+3.88%
P/S Ratio
0.91
Revenue / Employee
32.80M
Employees
4,612
Market Cap
137.75B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 150.26B | 7.07B | 4.94% |
| Mar 31, 2025 | 143.19B | 5.23B | 3.79% |
| Mar 31, 2024 | 137.96B | -21.50B | -13.48% |
| Mar 31, 2023 | 159.46B | -26.61B | -14.30% |
| Mar 31, 2022 | 186.07B | 47.50B | 34.28% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.62T |
| Otsuka Holdings | 2.62T |
| Chugai Pharmaceutical | 1.34T |
| HOYA Corporation | 983.64B |
| Genky DrugStores | 220.64B |
| Menicon | 127.73B |
| Mochida Pharmaceutical | 122.04B |
| JINS HOLDINGS | 108.13B |
BML, Inc. News
- 19 days ago - BML, Inc. Quarterly report: Q1 2027 - Filings
- 3 months ago - BML, Inc. Quarterly report: Q4 2026 - Filings
- 3 months ago - BML, Inc. Slides: Q4 2026 - Filings
- 7 months ago - BML, Inc. Quarterly report: Q3 2026 - Filings
- 10 months ago - BML, Inc. Quarterly report: Q2 2026 - Filings
- 10 months ago - BML, Inc. Slides: Q2 2026 - Filings